Semerjian Harout insider trades
Semerjian Harout has filed 5 Form 4s with the SEC that we hold, for Crescent Biopharma, INC. (GLYC) (Chief Executive Officer, Director) and Geron Corp (GERN) (President and CEO, Director). Across all of them we count 1 purchase worth $32.2K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 25,000 shares of Crescent Biopharma, INC. worth $32.2K, dated 2022-11-11. The first filing on our record is dated 2022-01-25 and the latest 2025-08-08.
Crescent Biopharma, INC. (GLYC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-11 | P, purchase reported on Form 4 | 25,000 | $32.2K | 2022-11-14 |
Geron Corp (GERN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1809747) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms